This leads to the build up of excessive levels of the neurotransmitter, acetylcholine, at the skeletal neuromuscular junction and those synapses where acetylcholine receptors are located
Thus, the primary manifestations of acute cholinesterase inhibitor toxicity are those of cholinergic (neurotransmitter) hyperactivity. (Carlton, Simpson et al. 1998)